166 related articles for article (PubMed ID: 19239915)
1. The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew).
Parker LA; Limebeer CL; Rock EM; Litt DL; Kwiatkowska M; Piomelli D
Physiol Behav; 2009 Apr; 97(1):121-4. PubMed ID: 19239915
[TBL] [Abstract][Full Text] [Related]
2. Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus).
O'Brien LD; Limebeer CL; Rock EM; Bottegoni G; Piomelli D; Parker LA
Br J Pharmacol; 2013 Nov; 170(5):1130-6. PubMed ID: 23991698
[TBL] [Abstract][Full Text] [Related]
3. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
Cross-Mellor SK; Ossenkopp KP; Piomelli D; Parker LA
Psychopharmacology (Berl); 2007 Feb; 190(2):135-43. PubMed ID: 17111174
[TBL] [Abstract][Full Text] [Related]
4. The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys.
Stewart JL; McMahon LR
Br J Pharmacol; 2011 Sep; 164(2b):655-66. PubMed ID: 21449917
[TBL] [Abstract][Full Text] [Related]
5. FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats.
Manwell LA; Satvat E; Lang ST; Allen CP; Leri F; Parker LA
Pharmacol Biochem Behav; 2009 Nov; 94(1):154-62. PubMed ID: 19698735
[TBL] [Abstract][Full Text] [Related]
6. 2-arachidonoylglycerol interferes with lithium-induced vomiting in the house musk shrew, Suncus murinus.
Sticht MA; Rock EM; Parker LA
Physiol Behav; 2013 Aug; 120():228-32. PubMed ID: 23958470
[TBL] [Abstract][Full Text] [Related]
7. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
Vlachou S; Nomikos GG; Panagis G
Psychopharmacology (Berl); 2006 Oct; 188(3):293-305. PubMed ID: 16953388
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.
Limebeer CL; Abdullah RA; Rock EM; Imhof E; Wang K; Lichtman AH; Parker LA
Psychopharmacology (Berl); 2014 Feb; 231(3):603-12. PubMed ID: 24043345
[TBL] [Abstract][Full Text] [Related]
10. Anandamide modulates the neuroendocrine responses induced by extracellular volume expansion.
Ruginsk SG; Uchoa ET; Elias LL; Antunes-Rodrigues J
Clin Exp Pharmacol Physiol; 2013 Oct; 40(10):698-705. PubMed ID: 23875874
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
[TBL] [Abstract][Full Text] [Related]
12. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade.
Forget B; Coen KM; Le Foll B
Psychopharmacology (Berl); 2009 Sep; 205(4):613-24. PubMed ID: 19484221
[TBL] [Abstract][Full Text] [Related]
14. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.
Malek N; Mrugala M; Makuch W; Kolosowska N; Przewlocka B; Binkowski M; Czaja M; Morera E; Di Marzo V; Starowicz K
Pain; 2015 May; 156(5):890-903. PubMed ID: 25719612
[TBL] [Abstract][Full Text] [Related]
15. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
16. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation.
Makwana R; Molleman A; Parsons ME
Br J Pharmacol; 2010 Jun; 160(3):615-26. PubMed ID: 20590566
[TBL] [Abstract][Full Text] [Related]
17. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.
Hill MN; McLaughlin RJ; Morrish AC; Viau V; Floresco SB; Hillard CJ; Gorzalka BB
Neuropsychopharmacology; 2009 Dec; 34(13):2733-45. PubMed ID: 19710634
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley JM; Guindon J; Hohmann AG
Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
[TBL] [Abstract][Full Text] [Related]
20. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.
Seillier A; Martinez AA; Giuffrida A
Neuropsychopharmacology; 2013 Aug; 38(9):1816-24. PubMed ID: 23563893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
